Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D.

Open Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan.

2.

Routine Broad-Range Fungal Polymerase Chain Reaction With DNA Sequencing in Patients With Suspected Mycoses Does Not Add Value and Is Not Cost-Effective.

Stempak LM, Vogel SA, Richter SS, Wyllie R, Procop GW.

Arch Pathol Lab Med. 2018 Dec 28. doi: 10.5858/arpa.2017-0299-OA. [Epub ahead of print]

PMID:
30605021
3.

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient.

Athans V, Neuner EA, Hassouna H, Richter SS, Keller G, Castanheira M, Brizendine KD, Mathers AJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01551-18. doi: 10.1128/AAC.01551-18. Print 2019 Jan.

PMID:
30578403
4.

ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases.

Jacobs MR, Abdelhamed AM, Good CE, Rhoads DD, Hujer KM, Hujer AM, Domitrovic TN, Rudin SD, Richter SS, van Duin D, Kreiswirth BN, Greco C, Fouts DE, Bonomo RA.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01801-18. doi: 10.1128/AAC.01801-18. Print 2019 Jan.

PMID:
30323050
5.

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S 3rd, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD.

Clin Infect Dis. 2018 Aug 31;67(6):813-816. doi: 10.1093/cid/ciy584.

PMID:
30169655
6.

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S 3rd, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD.

Clin Infect Dis. 2018 Aug 31;67(6):e1-e94. doi: 10.1093/cid/ciy381.

PMID:
29955859
7.

Reply to Beal et al., 'The "3-Day Rule" for Stool Tests May Not Apply When Using PCR Panels'.

Procop GW, Nikolic D, Asamoto K, Wyllie R, Tuttle R, Richter SS.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e02029-17. doi: 10.1128/JCM.02029-17. Print 2018 Apr. No abstract available.

8.

Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.

Richter SS, Karichu J, Otiso J, Van Heule H, Keller G, Cober E, Rojas LJ, Hujer AM, Hujer KM, Marshall S, Perez F, Rudin SD, Domitrovic TN, Kaye KS, Salata R, van Duin D, Bonomo RA.

Diagn Microbiol Infect Dis. 2018 May;91(1):89-92. doi: 10.1016/j.diagmicrobio.2018.01.005. Epub 2018 Jan 9.

PMID:
29456071
9.

Performance of the BacT/Alert Virtuo Microbial Detection System for the culture of sterile body fluids: prospective multicentre study.

She RC, Romney MG, Jang W, Walker T, Karichu JK, Richter SS.

Clin Microbiol Infect. 2018 Sep;24(9):992-996. doi: 10.1016/j.cmi.2017.12.011. Epub 2017 Dec 20.

10.

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy.

Eilertson B, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, DeHovitz J, Kreiswirth B, van Duin D; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2017 Oct 6;4(4):ofx216. doi: 10.1093/ofid/ofx216. eCollection 2017 Fall.

11.

A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae.

Henig O, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Evans S, Fowler VG Jr, Bonomo RA, van Duin D, Kaye KS; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2017 Jul 27;4(3):ofx157. doi: 10.1093/ofid/ofx157. eCollection 2017 Summer.

12.

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.

van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Fowler VG Jr, Paterson DL, Bonomo RA, Evans S; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2018 Jan 6;66(2):163-171. doi: 10.1093/cid/cix783.

13.

Implementation of a Clinical Decision Support Tool for Stool Cultures and Parasitological Studies in Hospitalized Patients.

Nikolic D, Richter SS, Asamoto K, Wyllie R, Tuttle R, Procop GW.

J Clin Microbiol. 2017 Dec;55(12):3350-3354. doi: 10.1128/JCM.01052-17. Epub 2017 Sep 27.

14.

Impact of antimicrobial stewardship and rapid microarray testing on patients with Gram-negative bacteremia.

Rivard KR, Athans V, Lam SW, Gordon SM, Procop GW, Richter SS, Neuner E.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1879-1887. doi: 10.1007/s10096-017-3008-6. Epub 2017 May 23.

PMID:
28534213
15.

NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas.

Rojas LJ, Hujer AM, Rudin SD, Wright MS, Domitrovic TN, Marshall SH, Hujer KM, Richter SS, Cober E, Perez F, Adams MD, van Duin D, Bonomo RA.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00454-17. doi: 10.1128/AAC.00454-17. Print 2017 Jul.

16.

The Ongoing Genetic Adaptation of Streptococcus pneumoniae.

Richter SS, Musher DM.

J Clin Microbiol. 2017 Mar;55(3):681-685. doi: 10.1128/JCM.02283-16. Epub 2016 Dec 14.

17.

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.

Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2017 Mar 15;64(6):711-718. doi: 10.1093/cid/ciw805.

18.

Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Richter SS, Marchaim D.

Virulence. 2017 May 19;8(4):417-426. doi: 10.1080/21505594.2016.1255381. Epub 2016 Nov 4. Review.

19.

Inquilinus limosus in pulmonary disease: case report and review of the literature.

McHugh KE, Rhoads DD, Wilson DA, Highland KB, Richter SS, Procop GW.

Diagn Microbiol Infect Dis. 2016 Dec;86(4):446-449. doi: 10.1016/j.diagmicrobio.2016.09.006. Epub 2016 Sep 16. Review.

PMID:
27717651
20.

Experience With Rapid Microarray-Based Diagnostic Technology and Antimicrobial Stewardship for Patients With Gram-Positive Bacteremia.

Neuner EA, Pallotta AM, Lam SW, Stowe D, Gordon SM, Procop GW, Richter SS.

Infect Control Hosp Epidemiol. 2016 Nov;37(11):1361-1366. Erratum in: Infect Control Hosp Epidemiol. 2017 Mar;38(3):385.

PMID:
27767002
21.

The presence of a single MALDI-TOF mass spectral peak predicts methicillin resistance in staphylococci.

Rhoads DD, Wang H, Karichu J, Richter SS.

Diagn Microbiol Infect Dis. 2016 Nov;86(3):257-261. doi: 10.1016/j.diagmicrobio.2016.08.001. Epub 2016 Aug 7.

PMID:
27568365
22.

Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.

Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D; Antibacterial Resistance Leadership Group.

Clin Microbiol Infect. 2016 Jun;22(6):513-9. doi: 10.1016/j.cmi.2016.01.023. Epub 2016 Feb 3.

23.

Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013.

Richter SS, Doern GV, Heilmann KP, Miner S, Tendolkar S, Riahi F, Diekema DJ.

J Clin Microbiol. 2016 Mar;54(3):812-4. doi: 10.1128/JCM.03109-15. Epub 2016 Jan 13.

24.

Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.

Messina JA, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Bonomo RA, Fowler VG, van Duin D; Antibacterial Resistance Leadership Group.

Infect Control Hosp Epidemiol. 2016 Mar;37(3):281-8. doi: 10.1017/ice.2015.298. Epub 2015 Dec 21.

25.

Utility of PCR, Culture, and Antigen Detection Methods for Diagnosis of Legionellosis.

Chen DJ, Procop GW, Vogel S, Yen-Lieberman B, Richter SS.

J Clin Microbiol. 2015 Nov;53(11):3474-7. doi: 10.1128/JCM.01808-15. Epub 2015 Aug 19.

26.

Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.

van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA, Kaye KS.

Infect Control Hosp Epidemiol. 2015 Aug;36(8):942-8. doi: 10.1017/ice.2015.118. Epub 2015 May 20.

27.

Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.

van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG Jr, Kaye KS, Bonomo RA.

J Antimicrob Chemother. 2015 Apr;70(4):1203-11. doi: 10.1093/jac/dku495. Epub 2014 Dec 9.

28.

Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.

Brizendine KD, Richter SS, Cober ED, van Duin D.

Antimicrob Agents Chemother. 2015 Jan;59(1):553-7. doi: 10.1128/AAC.04284-14. Epub 2014 Nov 10.

29.

Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV.

Antimicrob Agents Chemother. 2014 Nov;58(11):6484-9. doi: 10.1128/AAC.03344-14. Epub 2014 Aug 18.

30.

Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.

van Duin D, Cober ED, Richter SS, Perez F, Cline M, Kaye KS, Kalayjian RC, Salata RA, Evans SR, Fowler VG Jr, Bonomo RA.

Clin Microbiol Infect. 2014 Dec;20(12):O1117-20. doi: 10.1111/1469-0691.12714. Epub 2014 Dec 12.

31.

Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.

van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Richter SS, Cline M, Hall GS, Kaye KS, Jacobs MR, Kalayjian RC, Salata RA, Segre JA, Conlan S, Evans S, Fowler VG Jr, Bonomo RA.

Antimicrob Agents Chemother. 2014 Jul;58(7):4035-41. doi: 10.1128/AAC.02636-14. Epub 2014 May 5.

32.

Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study.

Diekema DJ, Richter SS, Heilmann KP, Dohrn CL, Riahi F, Tendolkar S, McDanel JS, Doern GV.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):285-92. doi: 10.1086/675283. Epub 2014 Jan 29.

PMID:
24521595
33.

Identification of aerobic Gram-positive bacilli by use of Vitek MS.

Navas M, Pincus DH, Wilkey K, Sercia L, LaSalvia M, Wilson D, Procop GW, Richter SS.

J Clin Microbiol. 2014 Apr;52(4):1274-7. doi: 10.1128/JCM.03483-13. Epub 2014 Feb 5.

34.

Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria.

Branda JA, Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia LF, Westblade LF, Ferraro MJ.

Diagn Microbiol Infect Dis. 2014 Feb;78(2):129-31. doi: 10.1016/j.diagmicrobio.2013.08.013. Epub 2013 Dec 8.

PMID:
24321357
35.

Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Crispell EK, Riahi F, McDanel JS, Satola SW, Doern GV.

Antimicrob Agents Chemother. 2014;58(2):740-5. doi: 10.1128/AAC.01915-13. Epub 2013 Nov 18.

36.

Reply to "risks of 'blind' automated identification systems in medical microbiology".

Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA.

J Clin Microbiol. 2013 Nov;51(11):3912. doi: 10.1128/JCM.02349-13. No abstract available.

37.

Evaluation of pneumococcal serotyping by multiplex PCR and quellung reactions.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

J Clin Microbiol. 2013 Dec;51(12):4193-5. doi: 10.1128/JCM.01876-13. Epub 2013 Sep 11.

38.

Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli.

Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, Jennemann R, Lewinski MA, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Westblade LF, Ginocchio CC.

Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):337-46. doi: 10.1007/s10096-013-1961-2. Epub 2013 Sep 10.

PMID:
24019163
39.

Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS.

Clin Infect Dis. 2013 Aug;57(4):485-8. doi: 10.1093/cid/cit441.

40.

A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS.

Clin Infect Dis. 2013 Aug;57(4):e22-e121. doi: 10.1093/cid/cit278. Epub 2013 Jul 10.

41.

Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system.

Richter SS, Sercia L, Branda JA, Burnham CA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Rychert JA, Westblade LF, Procop GW.

Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1571-8. doi: 10.1007/s10096-013-1912-y. Epub 2013 Jul 2.

PMID:
23818163
42.

Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

Emerg Infect Dis. 2013 Jul;19(7):1074-83. doi: 10.3201/eid1907.121830.

43.

Multicenter study evaluating the Vitek MS system for identification of medically important yeasts.

Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA.

J Clin Microbiol. 2013 Jul;51(7):2267-72. doi: 10.1128/JCM.00680-13. Epub 2013 May 8.

44.

Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria.

Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia L, Westblade LF, Ferraro MJ, Branda JA.

J Clin Microbiol. 2013 Jul;51(7):2225-31. doi: 10.1128/JCM.00682-13. Epub 2013 May 8.

45.

Evaluation of the Verigene Gram-positive blood culture nucleic acid test for rapid detection of bacteria and resistance determinants.

Wojewoda CM, Sercia L, Navas M, Tuohy M, Wilson D, Hall GS, Procop GW, Richter SS.

J Clin Microbiol. 2013 Jul;51(7):2072-6. doi: 10.1128/JCM.00831-13. Epub 2013 Apr 17.

46.

Polymicrobial acute respiratory infections in a hospital-based pediatric population.

Chorazy ML, Lebeck MG, McCarthy TA, Richter SS, Torner JC, Gray GC.

Pediatr Infect Dis J. 2013 May;32(5):460-6. doi: 10.1097/INF.0b013e31828683ce.

47.

Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS 2nd, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL.

Clin Infect Dis. 2013 Mar;56(5):641-8. doi: 10.1093/cid/cis942. Epub 2012 Nov 13.

48.

Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients.

Marko DC, Saffert RT, Cunningham SA, Hyman J, Walsh J, Arbefeville S, Howard W, Pruessner J, Safwat N, Cockerill FR, Bossler AD, Patel R, Richter SS.

J Clin Microbiol. 2012 Jun;50(6):2034-9. doi: 10.1128/JCM.00330-12. Epub 2012 Apr 11.

49.

In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.

Doern GV, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Richter SS.

Antimicrob Agents Chemother. 2012 Jun;56(6):3406-8. doi: 10.1128/AAC.00582-12. Epub 2012 Apr 9.

50.

Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.

Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV.

J Clin Microbiol. 2011 Dec;49(12):4203-7. doi: 10.1128/JCM.01152-11. Epub 2011 Oct 5.

Supplemental Content

Loading ...
Support Center